Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Profit After Tax (2020 - 2025)

Historic Profit After Tax for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $4.0 million.

  • Bioventus' Profit After Tax rose 16850.21% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 12323.2%. This contributed to the annual value of -$43.8 million for FY2024, which is 7759.34% up from last year.
  • Per Bioventus' latest filing, its Profit After Tax stood at $4.0 million for Q3 2025, which was up 16850.21% from $9.3 million recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Profit After Tax peaked at $9.3 million during Q2 2025, and registered a low of -$174.4 million during Q2 2023.
  • For the 5-year period, Bioventus' Profit After Tax averaged around -$24.2 million, with its median value being -$6.4 million (2024).
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 632124.28% in 2022, then soared by 16850.21% in 2025.
  • Over the past 5 years, Bioventus' Profit After Tax (Quarter) stood at -$1.9 million in 2021, then crashed by 2270.47% to -$44.9 million in 2022, then soared by 82.94% to -$7.7 million in 2023, then surged by 134.13% to $2.6 million in 2024, then skyrocketed by 53.31% to $4.0 million in 2025.
  • Its Profit After Tax stands at $4.0 million for Q3 2025, versus $9.3 million for Q2 2025 and -$3.3 million for Q1 2025.